×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
3 Clinical Trials with Mixed to Disastrous Results: Sophiris, Merrimack and Pfizer
BioSpace
Although it's great to report on successful clinical trial results, the reality is that only about one in 10 drugs make it to approval.
70 months ago
Sophiris slides on prostate cancer data but vows to press on
Fierce Biotech
Sophiris slides on prostate cancer data but vows to press on ... Sophiris Bio is adamant that it will advance its lead drug topsalysin into phase...
64 months ago
Will a shot once a year cure prostate ailments?
San Diego Union-Tribune
As they age, many men are forced to deal with an enlarged prostate.
140 months ago
People in the News
Genetic Engineering and Biotechnology News
September 15, 2012 (Vol. 32, No. 16). Satendra S. Chauhan, Ph.D., is now CSO at Peptides International. Previously, Dr. Chauhan was director...
139 months ago
Benign Prostatic Hyperplasia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies ...
Barchart.com
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Benign Prostatic Hyperplasia pipeline constitutes 7+ key...
3 days ago
Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies
GlobeNewswire
With over 900 key pharmaceutical companies working, the Prostate cancer pipeline projects a robust and promising picture in near future,...
37 months ago
People: Ex-Novartis Chair Takes $25k Daily Consulting Job
outsourcing-pharma.com
The ex-Chairman at Novartis will stay on in a consulting role and there's a new CEO at Visterra - welcome to in-Pharmatechnologist's People...
129 months ago
Epirium Bio Appoints Alexander Casdin, Reneo Capital Management Founder, as Chief Financial Officer
Business Wire
Epirium Bio announces Alexander Casdin as their new CFO and Sandy Mahatme as their newest board member.
42 months ago
Mid-Afternoon Market Update: Dow Plunges Over 1300 Points As WHO Declares COVID-19 A Pandemic - Avid Bios
Benzinga
Toward the end of trading Wednesday, the Dow traded down 5.44% to 23,656.01 while the NASDAQ fell 4.91% to 7,934.22. The S&P also fell,...
49 months ago